$47.370
-1.781 (-3.76%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
GPCR Prediction & Forecast by Similar Chart Analysis
Alphio's GPCR stock price prediction model matches the current Structure Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $47.58 (+0.44%). The 1-week path is $49.18 (+3.82%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Structure Therapeutics Inc Stock?
Structure Therapeutics Inc (GPCR) is currently priced at $47.37, which is significantly lower than the analyst price target of $111 from Canaccord. However, the stock has a low RSI of 22.854, indicating it is oversold, but it also has a negative forward P/E ratio of 0, suggesting uncertainty about future earnings. The main risk is the declining net income, with a loss of $106,159,000 reported in Q2 2026, which raises concerns about the company's financial health.
GPCR stock price ended at $47.37 on Friday, after losing -3.76%
Structure Therapeutics Inc (GPCR) last closed at $47.37, losing -3.76%. These facts feed the 1-day and 1-week GPCR price prediction above.
Forecast Drivers
Structure Therapeutics Inc (GPCR) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bearish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches GPCR, ranked by similarity.
Seasonality analysis for GPCR
Historically the probability of a positive August return for GPCR is 3.17%. January offers the highest probability of a positive month at 65.57%, while May is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for GPCR
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $18.66 | $21.18 | $22.34 | -55.29% |
| Sep 2026 | $15.83 | $17.77 | $18.37 | -62.50% |
| Oct 2026 | $16.92 | $17.66 | $20.06 | -62.73% |
| Nov 2026 | $20.72 | $23.24 | $23.49 | -50.93% |
| Dec 2026 | $20.36 | $22.10 | $24.61 | -53.34% |
In 2026, Structure Therapeutics Inc (GPCR) is projected to range from $15.83 to $24.61.
Structure Therapeutics Inc 2026 monthly forecast
In Aug 2026, Structure Therapeutics Inc is projected to average $21.18, with a low of $18.66 and high of $22.34.
In Sep 2026, Structure Therapeutics Inc is projected to average $17.77, with a low of $15.83 and high of $18.37.
In Oct 2026, Structure Therapeutics Inc is projected to average $17.66, with a low of $16.92 and high of $20.06.
In Nov 2026, Structure Therapeutics Inc is projected to average $23.24, with a low of $20.72 and high of $23.49.
In Dec 2026, Structure Therapeutics Inc is projected to average $22.10, with a low of $20.36 and high of $24.61.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.